Market Cap 1.19B
Revenue (ttm) 3.93M
Net Income (ttm) -126.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,212.21%
Debt to Equity Ratio 0.00
Volume 6,397,000
Avg Vol 6,825,658
Day's Range N/A - N/A
Shares Out 297.97M
Stochastic %K 30%
Beta 1.61
Analysts Strong Sell
Price Target $8.25

Company Profile

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine an...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 556 9900
Address:
20374 Seneca Meadows Parkway, Germantown, United States
Bordeaux17
Bordeaux17 Oct. 31 at 7:59 PM
$PGEN Yeah, this week stung a bit, but zoom out a month and tell me again how this is extremely bearish. Must be that new reverse-psychology trading strategy.
1 · Reply
InvestorWisdom
InvestorWisdom Oct. 31 at 7:51 PM
$PGEN Looks like it wants to push off the 10/21/50DMA. They’re all tight.
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 31 at 10:22 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.05 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.46- $1.79 Scale out: $2.27-$2.93 Can Easily Capture: 60% ROI Blended DTE: 441 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 30 at 11:42 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.03 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.57- $1.93 Scale out: $2.45-$3.15 Can Easily Capture: 60% ROI Blended DTE: 442 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Wacousta
Wacousta Oct. 30 at 5:20 PM
$PGEN FYI https://investors.precigen.com/node/14591/html
5 · Reply
1ightningscalps
1ightningscalps Oct. 30 at 5:53 AM
1ightning® Options Trade Alert (Actionable) | Buy $PGEN Nov 21 $4 Call | Enter: $0.40 Exit: $0.61 | Profit: 53.15% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 29 at 11:28 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $3.99 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.44- $1.76 Scale out: $2.24-$2.88 Can Easily Capture: 60% ROI Blended DTE: 443 Days | Join Elites here: https://liquidtheta.com
0 · Reply
RayD73
RayD73 Oct. 29 at 6:57 PM
$SHORT.X covered 5 mill shares at beginning of this month, pressure is building as information forthcoming on commercial launch
0 · Reply
dsup
dsup Oct. 29 at 4:09 PM
$PGEN insane low volume today….
1 · Reply
Dragonfly41
Dragonfly41 Oct. 29 at 4:05 PM
$PGEN CAPR
0 · Reply
Latest News on PGEN
Precigen Announces Up to $125 Million Non-Dilutive Financing

Sep 3, 2025, 7:00 AM EDT - 2 months ago

Precigen Announces Up to $125 Million Non-Dilutive Financing


Precigen, Inc. - Special Call

Sep 2, 2025, 1:55 PM EDT - 2 months ago

Precigen, Inc. - Special Call


Undercovered Dozen: Precigen, ONEOK, Bitmine And More

Aug 22, 2025, 10:43 AM EDT - 2 months ago

Undercovered Dozen: Precigen, ONEOK, Bitmine And More

BMNR OKE


Precigen: This Billion-Dollar Approval Is Still Undervalued

Aug 15, 2025, 3:15 PM EDT - 2 months ago

Precigen: This Billion-Dollar Approval Is Still Undervalued


Why Is Precigen Stock Surging On Friday?

Aug 15, 2025, 9:48 AM EDT - 2 months ago

Why Is Precigen Stock Surging On Friday?


Precigen: August Is Pivotal For This Biotech Innovator

Jul 7, 2025, 5:58 PM EDT - 4 months ago

Precigen: August Is Pivotal For This Biotech Innovator


Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 7:47 PM EDT - 8 months ago

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript


Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:03 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript


Actym Therapeutics Appoints Thomas Smart as CEO

Apr 24, 2024, 9:00 AM EDT - 1 year ago

Actym Therapeutics Appoints Thomas Smart as CEO

ANAB XOMA


Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript

Mar 19, 2024, 8:49 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript


Precigen: RRP Targeting With AdenoVerse Technology Platform

Jan 19, 2024, 7:39 PM EST - 1 year ago

Precigen: RRP Targeting With AdenoVerse Technology Platform


Bordeaux17
Bordeaux17 Oct. 31 at 7:59 PM
$PGEN Yeah, this week stung a bit, but zoom out a month and tell me again how this is extremely bearish. Must be that new reverse-psychology trading strategy.
1 · Reply
InvestorWisdom
InvestorWisdom Oct. 31 at 7:51 PM
$PGEN Looks like it wants to push off the 10/21/50DMA. They’re all tight.
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 31 at 10:22 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.05 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.46- $1.79 Scale out: $2.27-$2.93 Can Easily Capture: 60% ROI Blended DTE: 441 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 30 at 11:42 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.03 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.57- $1.93 Scale out: $2.45-$3.15 Can Easily Capture: 60% ROI Blended DTE: 442 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Wacousta
Wacousta Oct. 30 at 5:20 PM
$PGEN FYI https://investors.precigen.com/node/14591/html
5 · Reply
1ightningscalps
1ightningscalps Oct. 30 at 5:53 AM
1ightning® Options Trade Alert (Actionable) | Buy $PGEN Nov 21 $4 Call | Enter: $0.40 Exit: $0.61 | Profit: 53.15% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 29 at 11:28 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $3.99 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.44- $1.76 Scale out: $2.24-$2.88 Can Easily Capture: 60% ROI Blended DTE: 443 Days | Join Elites here: https://liquidtheta.com
0 · Reply
RayD73
RayD73 Oct. 29 at 6:57 PM
$SHORT.X covered 5 mill shares at beginning of this month, pressure is building as information forthcoming on commercial launch
0 · Reply
dsup
dsup Oct. 29 at 4:09 PM
$PGEN insane low volume today….
1 · Reply
Dragonfly41
Dragonfly41 Oct. 29 at 4:05 PM
$PGEN CAPR
0 · Reply
1ightningscalps
1ightningscalps Oct. 29 at 8:34 AM
1ightning® Options Trade Alert (Actionable) | Buy $PGEN Nov 21 $4 Call | Enter: $0.48 Exit: $0.77 | Profit: 59.29% ROI | https://1ightning.com
0 · Reply
wallstbullinfinity
wallstbullinfinity Oct. 28 at 5:45 PM
$PGEN $MRNA 2 Companies that are all institutional hype... Watch how horrible they'll continue to perform. It's a new day... Big brotha institutions out, we the people in.
2 · Reply
GSD78626
GSD78626 Oct. 28 at 3:35 PM
$PGEN 🤮
0 · Reply
1ightningscalps
1ightningscalps Oct. 28 at 2:52 AM
1ightning® Options Trade Alert (Actionable) | Buy $PGEN Nov 21 $4 Call | Enter: $0.44 Exit: $0.56 | Profit: 27.04% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 27 at 11:33 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.36 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.57- $1.93 Scale out: $2.45-$3.15 Can Easily Capture: 60% ROI Blended DTE: 445 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Bordeaux17
Bordeaux17 Oct. 27 at 6:19 PM
$PGEN Starting to see a spike in chatter on the RRP support forums around Papzimeos. Dr. Smart’s webinar is now being shared and sparking a lot of discussion, mainly around efficacy and rollout timing. A few patients have already been lined up to receive treatment within the next six months. There’s also talk about when it might become available in Europe. Only real pushback so far is on the pricing — plenty of people unhappy with the cost, but overall awareness and anticipation are clearly ramping up.
3 · Reply
Deivittt
Deivittt Oct. 27 at 10:02 AM
$PGEN Novartis has announced the acquisition of Avidity for approximately $12 billion, integrating these programs into its neuromuscular portfolio. But the drugs remain experimental and have not yet been approved by the FDA. Furthermore, they are for patients with rare genetic diseases. So, what could $PGEN Precigen be worth with a billion-dollar drug approved, the rest of its pipeline, and its innovative and powerful platform?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 4:35 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.33 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.50- $1.83 Scale out: $2.33-$2.99 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 6:53 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $PGEN Current Share Price: $4.33 Contracts: $PGEN January 15, 2027 $4 Calls Scale in: $1.50- $1.83 Scale out: $2.33-$2.99 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
M22
M22 Oct. 24 at 11:00 PM
$PGEN I like the stock 💎🤲🏻
0 · Reply
Cat651
Cat651 Oct. 24 at 6:31 PM
$PGEN 6’6$ if copy & paste last relative uptrend that ended in 11$
1 · Reply
DenesSzabo
DenesSzabo Oct. 24 at 2:54 PM
$PGEN bought it @3,47 (15 of Oct) and would like to see 4,88 where I close half of the position. (Without Trump this ride has been much easier:))
0 · Reply